Science· 2026Q1
DNA origami vaccines program antigen-focused germinal centers
- 46citations
- Q1SCImago
- 2026year
Short summary
DNA origami-based virus-like particles (VLPs) expand rare B cells targeting HIV antigens more effectively than protein nanoparticles, by avoiding scaffold-specific immune responses.
AI-generated from the title and abstract; the full text is not read.
Key points
- DNA origami-VLPs were engineered for optimal display of HIV Env immunogen (eOD-GT8) and T cell help.
- DNA-VLPs expanded significantly higher frequencies of epitope-specific GC B cells than protein nanoparticles in mouse models.
- The DNA origami scaffold avoids competitor responses, focusing the GC response on the target antigen.
- A single immunization with optimized DNA-VLPs rapidly expanded subdominant broadly neutralizing antibody precursor B cells for HIV.
AI-generated from the title and abstract; the full text is not read.
Abstract
Recruitment and expansion of rare precursor B cells in germinal centers (GCs) is a central goal of vaccination to generate broadly neutralizing antibodies (bnAbs) against challenging pathogens such as HIV. Multivalent immunogen display is a well-established method to enhance vaccine-induced B cell responses, typically accomplished by using natural or engineered protein scaffolds. However, these scaffolds themselves are targets of antibody responses, with the potential to generate competitor scaffold-specific B cells that could theoretically limit expansion and maturation of "on-target" B cells in the GC response. Here, we rationally designed T-independent, DNA-origami based virus-like particles (VLPs) with optimal antigenic display of the germline targeting HIV Env immunogen, eOD-GT8, and appropriate T cell help to achieve a potent GC response. In preclinical mouse models, these DNA-VLPs expanded significantly higher frequencies of epitope-specific GC B cells compared with a state-of-the-art clinical protein nanoparticle. Optimized DNA-VLPs primed germinal centers focused on the target antigen and rapidly expanded subdominant broadly neutralizing antibody precursor B cells for HIV with a single immunization. Thus, avoiding scaffold-specific responses augments priming of bnAb precursor B cells, and DNA-VLPs are a promising platform for promoting B cell responses towards challenging subdominant epitopes.
The authors' abstract, as published at the source. Science, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
VirologyImmunology and Microbiology